Contact Us  
Home  |  About Us   |  Investor Services   
Issue Profiles
Onyx Biotec Ltd.
13-Nov-24  
18-Nov-24  
100  
 
58 - 61  
2000  
3444000  
1  
Objective
1. Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use.2. Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections.3. Prepayment or repayment of all or a portion of certain loans availed by our Company.4. General Corporate Purposes.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For    
Non-Institutional Investors     415166000    
Qualified Institutional Buyers     29634000    
Retail Individual Investors     190978000    
Business Description
Onyx started its operation in pharmaceutical industry with sterile water for injections in the year 2010. Since then,Onyx has been associated with th ...
Promoter's Holding
11803200  
4810000  
88.6  
65.1  
 
Address
Registrar
Listed at
Lead Manager
Promoters